GeneFerm Biotechnology Co., Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 72.587 million compared to TWD 83.829 million a year ago. Operating loss was TWD 4.276 million compared to operating Income of TWD 1.002 million a year ago. Net loss was TWD 4.804 million compared to net income of TWD 661,000 a year ago. Basic loss per share was TWD 0.17 compared to basic earnings per share of TWD 0.02 a year ago.